umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
METABOLIC PROFILES
AcureOmics AB.
Umeå University, Faculty of Science and Technology, Department of Chemistry. (Computational life science cluster (CLiC))
AcureOmics AB.
Anamar AB.
2012 (English)Patent (Other (popular science, discussion, etc.))
Abstract [en]

Abstract: The invention relates to the use of endogenous metabolites to produce a metabolic profile of a disorder or disease in a subject, e.g. an autoimmune disease, in particular rheumatoid arthritis, and the analysis of such metabolic profiles in order to find disturbances in such profiles in a subject which are caused by or correlated with the said diseases or disorders. Such disturbances can be normalised by treatment of the subject with specified compounds, particularly N-(2-chloro-3,4-dimethoxybenzylideneamino)guanidine or an aminoguanidine.

Place, publisher, year, edition, pages
2012.
National Category
Diagnostic Biotechnology
Identifiers
URN: urn:nbn:se:umu:diva-88201OAI: oai:DiVA.org:umu-88201DiVA: diva2:714281
Patent
20120108668
Available from: 2014-04-25 Created: 2014-04-25 Last updated: 2014-04-25

Open Access in DiVA

No full text

By organisation
Department of Chemistry
Diagnostic Biotechnology

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 243 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf